greeksoup/ stock research
Stock research / United States / WST / FY2008

West Pharmaceutical Services (WST) FY2008 results: revenue $1.1 billion

West Pharmaceutical Services Inc. (WST) reported revenue of $1.1 billion for fiscal 2008, the year ended 31 December 2008. Net income was $86 million, and diluted earnings per share $1.25. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2011.

Revenue
$1.1 billion
FY2008FY2008
Operating margin
11.8%
FY2008FY2008
Net income
$86 million
FY2008FY2008
Diluted EPS
$1.25
FY2008FY2008

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2008Last 8 years
Revenue1,051
Cost of revenue748
Gross profit303
Gross margin28.8%
Research and development18.7
Selling, general and administrative159
Operating income124
Operating margin11.8%
Interest expense16.0
Pre-tax income110
Income tax23.7
Effective tax rate21.6%
Net income86.0
Net margin8.2%
Diluted EPS$1.25
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2008Last 8 years
Operating cash flow135
Capital expenditure139
Free cash flow-3.6
Free cash flow margin-0.3%
Cash from investing-120
Cash from financing-29.4
Share-based compensation6.4
Buybacks5.2
Dividends paid18.6
Dividend per share$0.29
Diluted shares, weighted72m

Balance sheet

$ millionFY2008Last 8 years
Shareholders' equity487
Cash and equivalents87.2

10-K for the year ended 31 December 2008, filed 28 February 2011: the filing.